Susquehanna International Group, LLP Novo Nordisk A S Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $112 Million - $136 Million	937,500 Added 65.03%	2,379,100 $283 Million
Q2 2024 Aug 15, 2024	SELL	$122.71 - $146.91 $55.4 Million - $66.3 Million	-451,100 Reduced 23.83%	1,441,600 $206 Million
Q1 2024 May 07, 2024	BUY	$102.11 - $135.92 $107 Million - $142 Million	1,043,100 Added 122.78%	1,892,700 $243 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $36.1 Million - $43.4 Million	-411,300 Reduced 32.62%	849,600 $87.9 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $78.5 Million - $172 Million	862,900 Added 216.81%	1,260,900 $115 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $9.89 Million - $10.9 Million	63,400 Added 18.95%	398,000 $64.4 Million
Q1 2023 May 16, 2023	BUY	$132.34 - $159.14 $14.7 Million - $17.7 Million	111,000 Added 49.64%	334,600 $53.2 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $8.69 Million - $11.5 Million	84,700 Added 60.98%	223,600 $30.3 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $4.55 Million - $5.59 Million	47,800 Added 52.47%	138,900 $13.8 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $6.86 Million - $8.09 Million	-66,400 Reduced 42.16%	91,100 $10.2 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $4.81 Million - $5.82 Million	51,700 Added 48.87%	157,500 $17.5 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $3.16 Million - $3.86 Million	33,000 Added 45.33%	105,800 $11.9 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $6.83 Million - $8.63 Million	-80,900 Reduced 52.64%	72,800 $6.99 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $1.23 Million - $1.54 Million	18,200 Added 13.43%	153,700 $12.9 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $6.51 Million - $7.36 Million	-97,100 Reduced 41.75%	135,500 $9.14 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $9.91 Million - $11.4 Million	155,100 Added 200.13%	232,600 $16.2 Million
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $2.33 Million - $2.57 Million	-36,600 Reduced 32.08%	77,500 $5.38 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $579,546 - $672,606	-9,900 Reduced 7.98%	114,100 $7.47 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $994,146 - $1.3 Million	-20,100 Reduced 13.95%	124,000 $7.47 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $7.28 Million - $8.51 Million	-146,100 Reduced 50.34%	144,100 $8.34 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $8.53 Million - $9.59 Million	179,400 Added 161.91%	290,200 $15 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $870,294 - $975,942	18,600 Added 20.17%	110,800 $5.66 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $547,048 - $621,034	-11,800 Reduced 11.35%	92,200 $4.82 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $859,878 - $978,075	-20,700 Reduced 16.6%	104,000 $4.79 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $126,252 - $138,348	-2,700 Reduced 2.12%	124,700 $5.88 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $1.86 Million - $2.12 Million	42,100 Added 49.36%	127,400 $5.88 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $1.97 Million - $2.36 Million	40,600 Added 90.83%	85,300 $4.2 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $1.57 Million - $1.77 Million	-33,000 Reduced 42.47%	44,700 $2.4 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $3.2 Million - $3.82 Million	77,700	77,700 $3.74 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$2.13 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.51 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.51 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.4 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.29 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account